检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2015年
16期
2331-2332,2335
,共3页
李宏敏%陈琳%安宁%于瑞莲%何阳科%郭万君
李宏敏%陳琳%安寧%于瑞蓮%何暘科%郭萬君
리굉민%진림%안저%우서련%하양과%곽만군
华蟾素胶囊%唑来膦酸%骨转移%疼痛
華蟾素膠囊%唑來膦痠%骨轉移%疼痛
화섬소효낭%서래련산%골전이%동통
Cinobufacini capsules%zoledronic acid%bone metastases%pain
目的:探讨华蟾素胶囊联合唑来膦酸治疗恶性肿瘤骨转移疼痛的效果。方法选取2012年6月至2014年6月四川省人民医院肿瘤科收治的恶性肿瘤骨转移疼痛患者60例作为研究对象,随机分为对照组和治疗组。对照组单纯使用唑来膦酸治疗,治疗组在对照组基础上联合使用华蟾素胶囊,比较2组患者的治愈率及不良反应发生率。结果治疗组的恶性肿瘤骨转移疼痛治愈率为66.7%(20/30),对照组为36.7%(11/30),2组比较差异有统计学意义( P<0.05);治疗组不良反应发生率为43.3%(13/30),与对照组的46.7%(14/30)比较,差异无统计学意义(P>0.05)。结论华蟾素胶囊联合唑来膦酸治疗恶性肿瘤骨转移疼痛的效果较为明显,具有一定的推广价值。
目的:探討華蟾素膠囊聯閤唑來膦痠治療噁性腫瘤骨轉移疼痛的效果。方法選取2012年6月至2014年6月四川省人民醫院腫瘤科收治的噁性腫瘤骨轉移疼痛患者60例作為研究對象,隨機分為對照組和治療組。對照組單純使用唑來膦痠治療,治療組在對照組基礎上聯閤使用華蟾素膠囊,比較2組患者的治愈率及不良反應髮生率。結果治療組的噁性腫瘤骨轉移疼痛治愈率為66.7%(20/30),對照組為36.7%(11/30),2組比較差異有統計學意義( P<0.05);治療組不良反應髮生率為43.3%(13/30),與對照組的46.7%(14/30)比較,差異無統計學意義(P>0.05)。結論華蟾素膠囊聯閤唑來膦痠治療噁性腫瘤骨轉移疼痛的效果較為明顯,具有一定的推廣價值。
목적:탐토화섬소효낭연합서래련산치료악성종류골전이동통적효과。방법선취2012년6월지2014년6월사천성인민의원종류과수치적악성종류골전이동통환자60례작위연구대상,수궤분위대조조화치료조。대조조단순사용서래련산치료,치료조재대조조기출상연합사용화섬소효낭,비교2조환자적치유솔급불량반응발생솔。결과치료조적악성종류골전이동통치유솔위66.7%(20/30),대조조위36.7%(11/30),2조비교차이유통계학의의( P<0.05);치료조불량반응발생솔위43.3%(13/30),여대조조적46.7%(14/30)비교,차이무통계학의의(P>0.05)。결론화섬소효낭연합서래련산치료악성종류골전이동통적효과교위명현,구유일정적추엄개치。
Objective To investigate the effect of Cinobufacini capsules combined with zoledronic acid in trea‐ting bone metastases pain in malignant tumor .Methods 60 patients with bone metastases pain of malignant tumor were selected in our hospital from June 2012 to June 2014 were selected as the research subjects and randomly divided into the control group and the treatment group ,30 cases in each group .The control group was treated with zoledronic acid ,while on this basis the treatment group was combined with Cinobufotalin Capsules .The cure rate and the inci‐dence of side and toxic effects were compared between the two groups .Results The total effective rates in the treat‐ment group and the control group were 66 .7% (20/30) and 36 .7% (11/30) ,the difference was statistically significant (P<0 .05) .The incidence rate of side and toxic effects in the treatment group and the control group were 43 .3%(13/30) and 46 .7% (14/30) ,the difference was not statistically significant(P> 0 .05) .Conclusion The effect of Cinobufacini capsules combined with zoledronic acid in treating bone metastases pain of malignant tumor is more sig‐nificant and has certain popularization value .